Replies to post #243227 on Amarin Corp Plc (AMRN)

[Older/Poorer/Wiser]

I don't understand this Europe math.

Why isn't Europe valued on a par with the US market? That logic starts with the likely population x $1500/per patient/year.

Then everyone can argue over the Sales to Market Cap ratio used in a buyout.

How do you get the nominally larger EU market less then the US? (Include the UK in that for simplicity's sake). Fewer indications? There is a longer patent runway (I think).

Thanks for any clarifications - - - -